ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,609,006 | +478.7% | 1,005,808 | +461.2% | 0.01% | +400.0% |
Q2 2023 | $3,561,022 | +1.1% | 179,216 | -18.8% | 0.00% | 0.0% |
Q3 2022 | $3,521,000 | +162.2% | 220,586 | +126.0% | 0.00% | +100.0% |
Q2 2022 | $1,343,000 | +266.9% | 97,610 | +323.2% | 0.00% | – |
Q1 2022 | $366,000 | -92.4% | 23,065 | -89.6% | 0.00% | -100.0% |
Q4 2021 | $4,825,000 | -24.8% | 221,013 | +52.9% | 0.00% | -60.0% |
Q1 2021 | $6,414,000 | -50.5% | 144,560 | -38.8% | 0.01% | -44.4% |
Q4 2020 | $12,954,000 | +932.2% | 236,218 | +330.3% | 0.01% | +800.0% |
Q3 2020 | $1,255,000 | -70.8% | 54,892 | -73.2% | 0.00% | -83.3% |
Q2 2020 | $4,291,000 | +95.0% | 204,996 | +112.0% | 0.01% | +100.0% |
Q4 2019 | $2,201,000 | +290.9% | 96,702 | +100.0% | 0.00% | +200.0% |
Q3 2019 | $563,000 | -93.5% | 48,363 | -91.7% | 0.00% | -92.3% |
Q2 2019 | $8,717,000 | +8.8% | 581,124 | +27.3% | 0.01% | +8.3% |
Q1 2019 | $8,009,000 | +779.1% | 456,586 | +642.9% | 0.01% | +1100.0% |
Q4 2018 | $911,000 | -73.9% | 61,462 | -56.6% | 0.00% | -75.0% |
Q3 2018 | $3,484,000 | +90.5% | 141,503 | +51.9% | 0.00% | +100.0% |
Q2 2018 | $1,829,000 | +75.7% | 93,162 | +67.8% | 0.00% | +100.0% |
Q1 2018 | $1,041,000 | – | 55,506 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |